Press Release: Ombudsman: European Medicines Agency should disclose clinical reports on anti-obesity drugs

The European Ombudsman, P. Nikiforos Diamandouros, has called on the European Medicines Agency (EMA) in London to grant access to clinical study reports and trial protocols for two anti-obesity drugs. This follows a complaint from Danish researchers in the field of healthcare who wanted to conduct an independent analysis. EMA refused their request for public access to these documents on the grounds that disclosure would undermine the drug producers' commercial interests.